WHO ICTRP trial
Investigation of Nasal Deposition using a Medical Device (Nasal Mesh Nebuliser…
ACTRN12618000693224 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12618000693224 |
|---|---|
| Public title | Investigation of Nasal Deposition using a Medical Device (Nasal Mesh Nebuliser -NMN) |
| Scientific title | A single center, randomized, controlled, four way cross-over clinical study investigating the deposition of aerosol generated by the Nasal Mesh Nebulizer (NMN) prototype into the nasal cavity using radio-labelled saline at different pulse frequency in healthy volunteers. |
| Primary sponsor | AFT Pharmaceuticals Ltd. |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | chronic rhino-sinusitis; chronic rhino-sinusitis;Respiratory - Other respiratory disorders / diseases |
| Interventions | The intervention is the treatment of a single intranasal dose of 2ml radio-labelled saline (an isotonic saline solution will be mixed and delivered together with the technetium labelled diethylene triamine petaacetic acid (99m Tc-DTPA)… |
| Registration date | Apr 27, 2018 |
| Target size | 20 |
| Secondary IDs | AFT-MD-01 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: